Article
Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice.
Neurobiology of aging - 1 Jan 2014
Papadopoulos Panayiota, Tong Xin-Kang, Hamel Edith
Abstract excerpt
Cognitive and cerebrovascular deficits are 2 landmarks of Alzheimer's disease (AD) to target for effective therapy. Here, we evaluated the efficacy of simvastatin in bitransgenic A/T mice overexpressing a mutated form of the human amyloid precursor protein (APP(Swe,Ind)) and a constitutively active form of transforming growth factor-β1. These mice feature the AD amyloid beta (Aβ) and cerebrovascular pathology....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
